日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antipsychotic Efficacy and Safety of LB-102 in the Treatment of Adults With Acute Schizophrenia: A Randomized Clinical Trial

LB-102治疗成人急性精神分裂症的抗精神病疗效和安全性:一项随机临床试验

Eramo, Anna; Correll, Christoph U; Walling, David P; Kakar, Rishi; Bassani, Niccolo; Callahan, Leslie; Lee, Baker P; Prensky, Zachary; Vaino, Andrew R; Kane, John M

Semaglutide and Early-Stage Metabolic Abnormalities in Individuals With Schizophrenia Spectrum Disorders: A Randomized Clinical Trial

司美格鲁肽治疗精神分裂症谱系障碍患者早期代谢异常:一项随机临床试验

Sass, Marie R; Klausen, Mette Kruse; Schwarz, Christine R; Rasmussen, Line; Giver, Malte E B; Hviid, Malthe; Schilling, Christoffer; Zamorski, Alexandra; Jensen, Andreas; Gefke, Maria; Storgaard, Heidi; Oturai, Peter S; Kjaer, Andreas; Hartmann, Bolette; Holst, Jens J; Ekstrøm, Claus T; Vinberg, Maj; Correll, Christoph U; Vilsbøll, Tina; Fink-Jensen, Anders

Global trends in clozapine utilisation between 2014 and 2024: a longitudinal epidemiological study with data from 75 countries

2014年至2024年氯氮平使用情况的全球趋势:一项基于75个国家数据的纵向流行病学研究

Fitzgerald, Ita; O'Dwyer, Sarah; Dhubhlaing, Ciara Ní; Gee, Siobhan; Sahm, Laura J; Wheeler, Amanda; Hurley, Eoin; Saastamoinen, Leena; Waksmundzka-Walczuk, Anna; Donohue, Grainne; Shiers, David; Gupta, Veenu; Howe, Jo; Correll, Christoph U; Højlund, Mikkel

Corrigendum to "Pro-dopaminergic pharmacological interventions for anhedonia in depression: a living systematic review and network meta-analysis of human and animal studies", EBioMedicine. 2025 Nov;121:105967. doi: 10.1016/j.ebiom.2025.105967

更正:“促多巴胺能药物干预治疗抑郁症快感缺失:一项关于人类和动物研究的动态系统评价和网络荟萃分析”,EBioMedicine. 2025 年 11 月;121:105967。doi:10.1016/j.ebiom.2025.105967

Ostinelli, Edoardo G; Salanti, Georgia; Macleod, Malcolm; Chiocchia, Virginia; Smith, Katharine A; Stringaris, Argyris; Downs, James; Robinson, Emma S J; Malhi, Gin S; Dwyer, Dominic M; Chevance, Astrid; Correll, Christoph; Tonia, Thomy; Wheeler, Emily; Furukawa, Toshi A; Pizzagalli, Diego A; Browning, Michael; Potts, Jennifer; Cipriani, Andrea

Development and validation of a prognostic model and risk calculator for the estimation of bipolar-spectrum disorder risk in hospitalised adolescents with non-psychotic/non-bipolar mental disorders

开发和验证用于评估住院非精神病性/非双相情感障碍青少年罹患双相情感障碍谱系障碍风险的预后模型和风险计算器

Salazar de Pablo, Gonzalo; Radua, Joaquim; Frearson, Grace; Young, Allan H; Arango, Celso; Kelleher, Ian; Sharma, Aditya; Uhlhaas, Peter J; Solmi, Marco; Fusar-Poli, Paolo; Guinart, Daniel; Correll, Christoph U

Correction: Antipsychotic‑Related Prolactin Changes: A Systematic Review and Dose-Response Meta‑analysis

更正:抗精神病药物相关催乳素变化:系统评价和剂量反应荟萃分析

Lin, Xiao; Siafis, Spyridon; Tian, Jing; Wu, Hui; Qin, Mengchang; Correll, Christoph U; Schneider-Thoma, Johannes; Leucht, Stefan

Effects of Long-Term Treatment with TV-46000 on Symptom Improvement Over Time in Stabilized Patients with Schizophrenia

TV-46000长期治疗对病情稳定的精神分裂症患者症状改善的影响

Kane, John M; Tohami, Orna; Franzenburg, Kelli R; Suett, Mark; Sharon, Nir; Merenlender-Wagner, Avia; Eshet, Roy; Harary, Eran; Correll, Christoph U

Correction: Effects of Long-Term Treatment with TV-46000 on Symptom Improvement Over Time in Stabilized Patients with Schizophrenia

更正:TV-46000长期治疗对病情稳定的精神分裂症患者症状随时间改善的影响

Kane, John M; Tohami, Orna; Franzenburg, Kelli R; Suett, Mark; Sharon, Nir; Merenlender-Wagner, Avia; Eshet, Roy; Harary, Eran; Correll, Christoph U

Ensuring generalizability and clinical utility in mental health care applications: Robust artificial intelligence-based treatment predictions in diverse psychosis populations

确保在精神卫生保健应用中的普适性和临床实用性:针对不同精神病人群的稳健的基于人工智能的治疗预测

Coutts, Fiona; Mena, Sergio; Ucur, Esin; Fleischhacker, W Wolfgang; Kahn, Rene; Lieberman, Jeffrey; Hasan, Alkomiet; Howes, Oliver; Correll, Christoph; Koutsouleris, Nikolaos; Lalousis, Paris Alexandros

Reduced risk of cause-specific hospitalisations and all-cause hospitalisation/mortality during treatment with attention-deficit/hyperactivity disorder medications in the course of bipolar disorder: a Swedish registry-based within-subject cohort study

在双相情感障碍病程中使用注意力缺陷/多动障碍药物治疗可降低特定病因住院和全因住院/死亡风险:一项基于瑞典注册登记的受试者自身队列研究

Ermis, Cagatay; Tanskanen, Antti; Corbeil, Olivier; Lieslehto, Johannes; Vieta, Eduard; Correll, Christoph U; Mittendorfer-Rutz, Ellenor; Tiihonen, Jari; Taipale, Heidi